Hedge Funds Are Bullish About These Stocks [View article]
Ha! That's laughable! The time to own a biotech stock like PPHM is on the progress thru the various trial stages with positive feedback from the FDA, not once the company is profitable, how funny! Yesterday PPHM got orphan drug status and support from FDA on III Trail for brain cancer...this is a strong buy after data was corrupted on other trial brought stock down from $4 to .75
As tempted as I am to short this stock with downward momentum I fear that it is one monetization press release away from a knock your socks up short covering rally.
Hedge Funds Are Bullish About These Stocks [View article]
Facebook Model Update: Lowering Price Target; Remain 'Equal Weight' [View article]